Folic Acid-Conjugated Magnetic Oleoyl-Chitosan Nanoparticles for Controlled Release of Doxorubicin in Cancer Therapy
Nanomaterials · 07.03.2025 · 15 (6) · 415
DOI: 10.3390/nano15060415 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nanomaterials, online erschienen am 07.03.2025. Verfasst von Banendu Sunder Dash und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical and Materials Engineering, Chang Gung University, Kwei-San, Taoyuan 33302, Taiwan. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chang Gung Memorial Hospital, the National Science and Technology Council, Taiwan.
Abstract (Originalsprache)
To develop an efficient drug delivery system, we co-entrapped superparamagnetic Fe3O4 and the chemotherapeutic drug doxorubicin (DOX) in oleoyl-chitosan (OC) to prepare DOX-entrapped magnetic OC (DOX-MOC) nanoparticles (NPs) through ionic gelation of OC with sodium tripolyphosphate (TPP). The NPs provide magnetically targeted delivery of DOX in cancer therapy. Using folic acid (FA)-grafted OC, FA-conjugated DOX-entrapped magnetic OC (FA-DOX-MOC) NPs were prepared similarly for FA-mediated active targeting of cancer cells with overexpressed folate receptors. Considering DOX loading and release, the best conditions for preparing DOX-MOC NPs were an OC:TPP mass ratio = 1:4 and OC concentration = 0.2%. These spherical NPs had a particle size of ~250 nm, 87.9% Fe3O4 content, 53.1 emu/g saturation magnetization, 83.1% drug encapsulation efficacy, and 2.81% drug loading efficiency. FA did not significantly change the physico-chemical characteristics of FA-DOX-MOC compared to DOX-MOC, and both NPs showed pH-dependent drug release behaviors, with much faster release of DOX at acidic pH values found in endosomes. However, FA could enhance the intracellular uptake of the NPs and DOX accumulation in the nucleus. This active targeting effect led to significantly higher cytotoxicity towards U87 cancer cells. These results suggest that FA-DOX-MOC NPs can efficiently deliver DOX for controlled drug release in cancer therapy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Chemical and Materials Engineering, Chang Gung University, Kwei-San, Taoyuan 33302, Taiwan.
- Department of Neurosurgery, Chang Gung Memorial Hospital at Linkou, Kwei-San, Taoyuan 33305, Taiwan.
- Research Center for Food and Cosmetic Safety, College of Human Ecology, Chang Gung University of Science and Technology, Taoyuan 33305, Taiwan.
- Department of Materials Engineering, Ming Chi University of Technology, Tai-Shan, New Taipei City 24301, Taiwan.
ORCID-Profile: Banendu Sunder Dash, Jyh-Ping Chen
Förderung
- Chang Gung Memorial Hospital
- the National Science and Technology Council, Taiwan
Zitieren
APA
Dash, B. S., Lai, Y. C., & Chen, J. P. (2025). Folic Acid-Conjugated Magnetic Oleoyl-Chitosan Nanoparticles for Controlled Release of Doxorubicin in Cancer Therapy. Nanomaterials, 15(6), 415. https://doi.org/10.3390/nano15060415
Vancouver
Dash BS, Lai YC, Chen JP. Folic Acid-Conjugated Magnetic Oleoyl-Chitosan Nanoparticles for Controlled Release of Doxorubicin in Cancer Therapy. Nanomaterials. 2025;15(6):415. doi:10.3390/nano15060415
BibTeX
@article{Dash2025,
author = {Dash, Banendu Sunder and Lai, Yi-Chian and Chen, Jyh-Ping},
title = {Folic Acid-Conjugated Magnetic Oleoyl-Chitosan Nanoparticles for Controlled Release of Doxorubicin in Cancer Therapy},
journal = {Nanomaterials},
year = {2025},
volume = {15},
number = {6},
pages = {415},
doi = {10.3390/nano15060415}
}
EUVIMED